Business · 19/08/2011
FDA Clears PENTETATE ZINC TRISODIUM Solution for Intravenous or Inhalation Administration
The FDA has determined that the PENTETATE ZINC TRISODIUM solution, used for intravenous or inhalation administration, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Original source language: Federal Register — Health and Human ServicesOpen original release →